Impact of COVID-19 Outbreak on Vaccine Vial, Global Market Research Report 2020

    • ID: AR2932488
    • 27 May, 2020
    • Chemical & Material
    • Region: Global
    • 118 Pages
    • QYResearch

    1 Vaccine Vial Market Overview

    • 1.1 Product Overview and Scope of Vaccine Vial
    • 1.2 Covid-19 Impact on Vaccine Vial Segment by Type
      • 1.2.1 Global Vaccine Vial Sales Growth Rate Comparison by Type (2021-2026)
      • 1.2.2 Single Dose
      • 1.2.3 Multi-dose
    • 1.3 Covid-19 Impact on Vaccine Vial Segment by Application
      • 1.3.1 Vaccine Vial Sales Comparison by Application: 2020 VS 2026
      • 1.3.2 Preventive Vaccine
      • 1.3.3 Therapeutic Vaccine
    • 1.4 Covid-19 Impact on Global Vaccine Vial Market Size Estimates and Forecasts
      • 1.4.1 Global Vaccine Vial Revenue 2015-2026
      • 1.4.2 Global Vaccine Vial Sales 2015-2026
      • 1.4.3 Vaccine Vial Market Size by Region: 2020 Versus 2026
    • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
      • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
      • 1.5.2 Covid-19 Impact: Commodity Prices Indices
      • 1.5.3 Covid-19 Impact: Global Major Government Policy
    • 1.6 The Covid-19 Impact on Vaccine Vial Industry
    • 1.7 COVID-19 Impact: Vaccine Vial Market Trends

    2 Covid-19 Impact on Global Vaccine Vial Market Competition by Manufacturers

    • 2.1 Global Vaccine Vial Sales Market Share by Manufacturers (2015-2020)
    • 2.2 Global Vaccine Vial Revenue Share by Manufacturers (2015-2020)
    • 2.3 Global Vaccine Vial Average Price by Manufacturers (2015-2020)
    • 2.4 Manufacturers Vaccine Vial Manufacturing Sites, Area Served, Product Type
    • 2.5 Vaccine Vial Market Competitive Situation and Trends
      • 2.5.1 Vaccine Vial Market Concentration Rate
      • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
      • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 2.7 Primary Interviews with Key Vaccine Vial Players (Opinion Leaders)

    3 Covid-19 Impact on Vaccine Vial Retrospective Market Scenario by Region

    • 3.1 Global Vaccine Vial Retrospective Market Scenario in Sales by Region: 2015-2020
    • 3.2 Global Vaccine Vial Retrospective Market Scenario in Revenue by Region: 2015-2020
    • 3.3 North America Vaccine Vial Market Facts & Figures by Country
      • 3.3.1 North America Vaccine Vial Sales by Country
      • 3.3.2 North America Vaccine Vial Sales by Country
      • 3.3.3 U.S.
      • 3.3.4 Canada
    • 3.4 Europe Vaccine Vial Market Facts & Figures by Country
      • 3.4.1 Europe Vaccine Vial Sales by Country
      • 3.4.2 Europe Vaccine Vial Sales by Country
      • 3.4.3 Germany
      • 3.4.4 France
      • 3.4.5 U.K.
      • 3.4.6 Italy
      • 3.4.7 Russia
    • 3.5 Asia Pacific Vaccine Vial Market Facts & Figures by Region
      • 3.5.1 Asia Pacific Vaccine Vial Sales by Region
      • 3.5.2 Asia Pacific Vaccine Vial Sales by Region
      • 3.5.3 China
      • 3.5.4 Japan
      • 3.5.5 South Korea
      • 3.5.6 India
      • 3.5.7 Australia
      • 3.5.8 Taiwan
      • 3.5.9 Indonesia
      • 3.5.10 Thailand
      • 3.5.11 Malaysia
      • 3.5.12 Philippines
      • 3.5.13 Vietnam
    • 3.6 Latin America Vaccine Vial Market Facts & Figures by Country
      • 3.6.1 Latin America Vaccine Vial Sales by Country
      • 3.6.2 Latin America Vaccine Vial Sales by Country
      • 3.6.3 Mexico
      • 3.6.3 Brazil
      • 3.6.3 Argentina
    • 3.7 Middle East and Africa Vaccine Vial Market Facts & Figures by Country
      • 3.7.1 Middle East and Africa Vaccine Vial Sales by Country
      • 3.7.2 Middle East and Africa Vaccine Vial Sales by Country
      • 3.7.3 Turkey
      • 3.7.4 Saudi Arabia
      • 3.7.5 UAE

    4 Covid-19 Impact on Global Vaccine Vial Historic Market Analysis by Type

    • 4.1 Global Vaccine Vial Sales Market Share by Type (2015-2020)
    • 4.2 Global Vaccine Vial Revenue Market Share by Type (2015-2020)
    • 4.3 Global Vaccine Vial Price Market Share by Type (2015-2020)
    • 4.4 Global Vaccine Vial Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

    5 Covid-19 Impact on Global Vaccine Vial Historic Market Analysis by Application

    • 5.1 Global Vaccine Vial Sales Market Share by Application (2015-2020)
    • 5.2 Global Vaccine Vial Revenue Market Share by Application (2015-2020)
    • 5.3 Global Vaccine Vial Price by Application (2015-2020)

    6 Company Profiles and Key Figures in Vaccine Vial Business

    • 6.1 Cardinal Health
      • 6.1.1 Corporation Information
      • 6.1.2 Cardinal Health Description, Business Overview and Total Revenue
      • 6.1.3 Cardinal Health Vaccine Vial Sales, Revenue and Gross Margin (2015-2020)
      • 6.1.4 Cardinal Health Products Offered
      • 6.1.5 Cardinal Health Recent Development and Response to COVID-19
    • 6.2 Schott
      • 6.2.1 Schott Corporation Information
      • 6.2.2 Schott Description, Business Overview and Total Revenue
      • 6.2.3 Schott Vaccine Vial Sales, Revenue and Gross Margin (2015-2020)
      • 6.2.4 Schott Products Offered
      • 6.2.5 Schott Recent Development and Response to COVID-19
    • 6.3 Thermofisher Scientific
      • 6.3.1 Thermofisher Scientific Corporation Information
      • 6.3.2 Thermofisher Scientific Description, Business Overview and Total Revenue
      • 6.3.3 Thermofisher Scientific Vaccine Vial Sales, Revenue and Gross Margin (2015-2020)
      • 6.3.4 Thermofisher Scientific Products Offered
      • 6.3.5 Thermofisher Scientific Recent Development and Response to COVID-19
    • 6.4 Richland Glass
      • 6.4.1 Richland Glass Corporation Information
      • 6.4.2 Richland Glass Description, Business Overview and Total Revenue
      • 6.4.3 Richland Glass Vaccine Vial Sales, Revenue and Gross Margin (2015-2020)
      • 6.4.4 Richland Glass Products Offered
      • 6.4.5 Richland Glass Recent Development and Response to COVID-19
    • 6.5 Gerresheimer
      • 6.5.1 Gerresheimer Corporation Information
      • 6.5.2 Gerresheimer Description, Business Overview and Total Revenue
      • 6.5.3 Gerresheimer Vaccine Vial Sales, Revenue and Gross Margin (2015-2020)
      • 6.5.4 Gerresheimer Products Offered
      • 6.5.5 Gerresheimer Recent Development and Response to COVID-19
    • 6.6 Nipro
      • 6.6.1 Nipro Corporation Information
      • 6.6.2 Nipro Description, Business Overview and Total Revenue
      • 6.6.3 Nipro Vaccine Vial Sales, Revenue and Gross Margin (2015-2020)
      • 6.6.4 Nipro Products Offered
      • 6.6.5 Nipro Recent Development and Response to COVID-19
    • 6.7 Corning
      • 6.6.1 Corning Corporation Information
      • 6.6.2 Corning Description, Business Overview and Total Revenue
      • 6.6.3 Corning Vaccine Vial Sales, Revenue and Gross Margin (2015-2020)
      • 6.4.4 Corning Products Offered
      • 6.7.5 Corning Recent Development and Response to COVID-19
    • 6.8 Catalent
      • 6.8.1 Catalent Corporation Information
      • 6.8.2 Catalent Description, Business Overview and Total Revenue
      • 6.8.3 Catalent Vaccine Vial Sales, Revenue and Gross Margin (2015-2020)
      • 6.8.4 Catalent Products Offered
      • 6.8.5 Catalent Recent Development and Response to COVID-19
    • 6.9 DWK Life Sciences
      • 6.9.1 DWK Life Sciences Corporation Information
      • 6.9.2 DWK Life Sciences Description, Business Overview and Total Revenue
      • 6.9.3 DWK Life Sciences Vaccine Vial Sales, Revenue and Gross Margin (2015-2020)
      • 6.9.4 DWK Life Sciences Products Offered
      • 6.9.5 DWK Life Sciences Recent Development and Response to COVID-19
    • 6.10 Qorpak
      • 6.10.1 Qorpak Corporation Information
      • 6.10.2 Qorpak Description, Business Overview and Total Revenue
      • 6.10.3 Qorpak Vaccine Vial Sales, Revenue and Gross Margin (2015-2020)
      • 6.10.4 Qorpak Products Offered
      • 6.10.5 Qorpak Recent Development and Response to COVID-19
    • 6.11 Pacific Vial Manufacturing
      • 6.11.1 Pacific Vial Manufacturing Corporation Information
      • 6.11.2 Pacific Vial Manufacturing Vaccine Vial Description, Business Overview and Total Revenue
      • 6.11.3 Pacific Vial Manufacturing Vaccine Vial Sales, Revenue and Gross Margin (2015-2020)
      • 6.11.4 Pacific Vial Manufacturing Products Offered
      • 6.11.5 Pacific Vial Manufacturing Recent Development and Response to COVID-19
    • 6.12 Shandong Pharmaceutical Glass
      • 6.12.1 Shandong Pharmaceutical Glass Corporation Information
      • 6.12.2 Shandong Pharmaceutical Glass Vaccine Vial Description, Business Overview and Total Revenue
      • 6.12.3 Shandong Pharmaceutical Glass Vaccine Vial Sales, Revenue and Gross Margin (2015-2020)
      • 6.12.4 Shandong Pharmaceutical Glass Products Offered
      • 6.12.5 Shandong Pharmaceutical Glass Recent Development and Response to COVID-19
    • 6.13 Anhui Huaxin Glass
      • 6.13.1 Anhui Huaxin Glass Corporation Information
      • 6.13.2 Anhui Huaxin Glass Vaccine Vial Description, Business Overview and Total Revenue
      • 6.13.3 Anhui Huaxin Glass Vaccine Vial Sales, Revenue and Gross Margin (2015-2020)
      • 6.13.4 Anhui Huaxin Glass Products Offered
      • 6.13.5 Anhui Huaxin Glass Recent Development and Response to COVID-19
    • 6.14 JOTOP Glass
      • 6.14.1 JOTOP Glass Corporation Information
      • 6.14.2 JOTOP Glass Vaccine Vial Description, Business Overview and Total Revenue
      • 6.14.3 JOTOP Glass Vaccine Vial Sales, Revenue and Gross Margin (2015-2020)
      • 6.14.4 JOTOP Glass Products Offered
      • 6.14.5 JOTOP Glass Recent Development and Response to COVID-19
    • 6.15 Origin Ltd
      • 6.15.1 Origin Ltd Corporation Information
      • 6.15.2 Origin Ltd Vaccine Vial Description, Business Overview and Total Revenue
      • 6.15.3 Origin Ltd Vaccine Vial Sales, Revenue and Gross Margin (2015-2020)
      • 6.15.4 Origin Ltd Products Offered
      • 6.15.5 Origin Ltd Recent Development and Response to COVID-19
    • 6.16 Jinan Youlyy
      • 6.16.1 Jinan Youlyy Corporation Information
      • 6.16.2 Jinan Youlyy Vaccine Vial Description, Business Overview and Total Revenue
      • 6.16.3 Jinan Youlyy Vaccine Vial Sales, Revenue and Gross Margin (2015-2020)
      • 6.16.4 Jinan Youlyy Products Offered
      • 6.16.5 Jinan Youlyy Recent Development and Response to COVID-19
    • 6.17 Stevanato
      • 6.17.1 Stevanato Corporation Information
      • 6.17.2 Stevanato Vaccine Vial Description, Business Overview and Total Revenue
      • 6.17.3 Stevanato Vaccine Vial Sales, Revenue and Gross Margin (2015-2020)
      • 6.17.4 Stevanato Products Offered
      • 6.17.5 Stevanato Recent Development and Response to COVID-19
    • 6.18 Vetter Pharma
      • 6.18.1 Vetter Pharma Corporation Information
      • 6.18.2 Vetter Pharma Vaccine Vial Description, Business Overview and Total Revenue
      • 6.18.3 Vetter Pharma Vaccine Vial Sales, Revenue and Gross Margin (2015-2020)
      • 6.18.4 Vetter Pharma Products Offered
      • 6.18.5 Vetter Pharma Recent Development and Response to COVID-19

    7 Vaccine Vial Manufacturing Cost Analysis

    • 7.1 Vaccine Vial Key Raw Materials Analysis
      • 7.1.1 Key Raw Materials
      • 7.1.2 Key Raw Materials Price Trend
      • 7.1.3 Key Suppliers of Raw Materials
    • 7.2 Proportion of Manufacturing Cost Structure
    • 7.3 Manufacturing Process Analysis of Vaccine Vial
    • 7.4 Vaccine Vial Industrial Chain Analysis

    8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Vaccine Vial Distributors List
    • 8.3 Vaccine Vial Customers

    9 Market Dynamics

    • 9.1 Market Trends
    • 9.2 Opportunities and Drivers
    • 9.3 Challenges
    • 9.4 Porter's Five Forces Analysis

    10 Global Market Forecast

    • 10.1 Global Vaccine Vial Market Estimates and Projections by Type
      • 10.1.1 Global Forecasted Sales of Vaccine Vial by Type (2021-2026)
      • 10.1.2 Global Forecasted Revenue of Vaccine Vial by Type (2021-2026)
    • 10.2 Vaccine Vial Market Estimates and Projections by Application
      • 10.2.1 Global Forecasted Sales of Vaccine Vial by Application (2021-2026)
      • 10.2.2 Global Forecasted Revenue of Vaccine Vial by Application (2021-2026)
    • 10.3 Vaccine Vial Market Estimates and Projections by Region
      • 10.3.1 Global Forecasted Sales of Vaccine Vial by Region (2021-2026)
      • 10.3.2 Global Forecasted Revenue of Vaccine Vial by Region (2021-2026)
    • 10.4 North America Vaccine Vial Estimates and Projections (2021-2026)
    • 10.5 Europe Vaccine Vial Estimates and Projections (2021-2026)
    • 10.6 Asia Pacific Vaccine Vial Estimates and Projections (2021-2026)
    • 10.7 Latin America Vaccine Vial Estimates and Projections (2021-2026)
    • 10.8 Middle East and Africa Vaccine Vial Estimates and Projections (2021-2026)

    11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources
      • 12.3 Author List

      The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
      Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Vaccine Vial market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
      This report also analyzes the impact of Coronavirus COVID-19 on the Vaccine Vial industry.

      Segment by Type, the Vaccine Vial market is segmented into
      Single Dose
      Multi-dose

      Segment by Application
      Preventive Vaccine
      Therapeutic Vaccine

      Global Vaccine Vial Market: Regional Analysis
      The Vaccine Vial market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
      The key regions covered in the Vaccine Vial market report are:
      North America
      U.S.
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      Taiwan
      Indonesia
      Thailand
      Malaysia
      Philippines
      Vietnam
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE

      Global Vaccine Vial Market: Competitive Analysis
      This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

      The major players in global Vaccine Vial market include:
      Cardinal Health
      Schott
      Thermofisher Scientific
      Richland Glass
      Gerresheimer
      Nipro
      Corning
      Catalent
      DWK Life Sciences
      Qorpak
      Pacific Vial Manufacturing
      Shandong Pharmaceutical Glass
      Anhui Huaxin Glass
      JOTOP Glass
      Origin Ltd
      Jinan Youlyy
      Stevanato
      Vetter Pharma



      Summary:
      Vaccine Vial Market Research Report is about Vaccine Vial Industry study. Get complete Vaccine Vial market research report published after Market Study, Industrial Analysis with Trends & Statistics. Vaccine Vial Market Report is a syndicated report for Investors and Manufacturer to understand Market Demand, Growth, trends and Factor Influencing market in upcoming years.



      REPORT YOU MIGHT BE INTERESTED